Filing summary
Important entity mismatch: The supplied filing is Acxiom Corporation and subsidiaries’ Form 10-Q, not Liveramp Holdings, Inc. It covers the quarter ended December 31, 2012, and is unaudited. The filing identifies the nine months ended that date as fiscal 2013 year-to-date.
Financial performance
Amounts below are in U.S. dollars; financial statement figures are converted from thousands to millions where applicable.
- Quarter revenue: $273.1 million, down 2.8% from $280.9 million in the prior-year quarter. Operating income was $26.9 million versus $15.5 million; operating margin was approximately 9.9% versus 5.5%.
- Quarter earnings: Continuing-operations net earnings were $14.4 million versus $1.8 million; diluted EPS from continuing operations was $0.19 versus $0.02. Acxiom-attributable net earnings were $14.5 million versus $7.9 million. Prior-year results included $17.8 million of goodwill and intangible impairment expense and $0.8 million of discontinued-operations earnings.
- Nine-month revenue: $822.2 million, down 2.5% from $843.4 million. Operating income increased to $82.5 million from $63.3 million; operating margin was approximately 10.0% versus 7.5%. Continuing-operations net earnings rose to $44.0 million from $22.8 million, and diluted continuing-operations EPS rose to $0.57 from $0.28.
- Margins: Gross margin, calculated as revenue less cost of revenue, was approximately 23.5% for the quarter versus 23.8%, and 23.6% for the nine months versus 23.0%.
- Cash flow: Nine-month operating cash flow was $75.9 million, down from $173.0 million. Investing activities used $41.6 million and financing activities used $77.6 million. Cash declined by $43.4 million during the period to $186.2 million.
- Liquidity and debt: At December 31, cash was $186.2 million and current assets were $436.5 million against current liabilities of $211.0 million, for a current ratio of approximately 2.1. Debt totaled $260.6 million, including current installments, versus $278.2 million at March 31, 2012; cash exceeded debt by approximately $74.4 million.
- Capital returns: Acxiom repurchased 4.1 million shares for $62.7 million during the nine months. The filing reported $69.1 million remaining under the repurchase authorization at December 31, 2012; the program was later modified on February 5, 2013.
Material changes and context
- Revenue declined modestly, while operating income and continuing-operations earnings increased. Lower prior-year impairment expense and lower interest expense contributed to the comparison; nine-month interest expense fell to $9.7 million from $14.1 million.
- Operating cash flow fell substantially year over year. The cash flow statement shows larger outflows from accounts payable and other liabilities and deferred revenue, as well as increased receivables.
- The company had sold its background-screening unit, Acxiom Information Security Systems, in the quarter ended March 31, 2012. Its prior-year results are presented as discontinued operations.
- Cash and total assets decreased from March 31, 2012, while total debt also declined. Treasury-stock repurchases were a significant use of financing cash.
Outlook, risks, and unusual items
- The supplied text does not provide clear forward guidance or a quantified outlook. It cautions that interim results are not necessarily indicative of full-year results.
- Management says estimates and assumptions affect reported amounts and that actual results could differ. The filing references commitments and contingencies, but the supplied text does not provide clear details of specific material contingencies.
- The financial statements are unaudited. The supplied filing text is incomplete and does not include the full Management’s Discussion and Analysis, so detailed management commentary, risk discussion, and liquidity outlook cannot be summarized reliably.
Key facts for investors to verify
- Confirm the intended issuer and filing: this document is Acxiom Corporation’s 2012 Form 10-Q, not a Liveramp filing.
- Review the complete filing, particularly MD&A, legal proceedings, and the notes on debt, commitments, and contingencies.
- Investigate the drivers and sustainability of the sharp year-over-year decline in operating cash flow despite improved earnings.
- Verify the effect of share repurchases and the February 2013 authorization change on outstanding shares and capital allocation.